D-FAGOMINE FOR THE CONTROL OF INFLAMMATORY PROCESSES RELATED TO AN OVERACTIVATION OF THE HUMORAL IMMUNE RESPONSE

The present invention belongs to the field of nutraceuticals or functional agents with immunostimulating capacity for triggering mechanisms of the innate immune response at a mucosal level. More specifically, it refers to the use of the compound D- fagomine as immunostimulating agent of the innate i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ANTOLIN MATÉ, MARÍA, CARMEN, CALVO TORRAS, MARIA, DE LOS ANGELES, PUMAROLA SEGURA, SERGIO, LLOPIS PAGÉS, MARTA
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	FOODS OR FOODSTUFFS FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention belongs to the field of nutraceuticals or functional agents with immunostimulating capacity for triggering mechanisms of the innate immune response at a mucosal level. More specifically, it refers to the use of the compound D- fagomine as immunostimulating agent of the innate immune response in the mucosa and for the prevention or prophylaxis of inflammatory processes or diseases associated with an overactivation of the humoral immune response. The invention also relates to a composition comprising D-fagomine for the above referenced application. La présente invention appartient au domaine des nutraceutiques ou des agents fonctionnels à capacité immunostimulante pour déclencher des mécanismes de la réponse immunitaire innée à un niveau mucosal. Plus spécifiquement, l'invention concerne l'utilisation du composé D-fagomine en tant qu'agent immunostimulant de la réponse immunitaire innée dans les muqueuses et pour la prévention ou la prophylaxie de processus inflammatoires ou de maladies associés à une suractivation de la réponse immunitaire humorale. L'invention concerne également une composition comprenant de la D-fagomine pour l'application référencée ci-dessus.